Market Cap (In TWD)
8.64 Billion
Revenue (In TWD)
4.36 Billion
Net Income (In TWD)
126.24 Million
Avg. Volume
1.4 Million
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 70.8-121.0
- PE
- -
- EPS
- -
- Beta Value
- 0.763
- ISIN
- TW0004746003
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dr. Chen-Yu Cheng Ph.D.
- Employee Count
- -
- Website
- https://www.formosalab.com
- Ipo Date
- 2011-02-28
- Details
- Formosa Laboratories, Inc. produces and sells active pharmaceutical ingredients (APIs) worldwide. The company offers APIs in the areas of anticancer, anti-inflammatory and analgesic agents, MRI enhancing agents, cholesterol and phosphate binders, CNS agents, immunomodulators, respiratory agents, steroids, vitamin D derivatives, and antibiotics. It also provides contract development and manufacturing services; solutions for manufacturing antibody-drug conjugates; and injectable manufacturing services. The company was founded in 1995 and is based in Taoyuan City, Taiwan.
More Stocks
-
THYAO
-
6115
-
ACLIFAccelleron Industries AG
ACLIF
-
003520Yungjin Pharm. Co., Ltd.
003520
-
1402
-
SPKLU
-
0QFModerna, Inc.
0QF
-
077970STX Engine Co.,Ltd.
077970